Aim. To investigate the biomechanical effects of zoledronic acid (ZA) on femurs of female osteoporotic rats after follow-up periods of 9 and 12 months. Methods. Eighty female Wistar rats were prospectively assessed. At 60 days of age, the animals were randomly divided into two groups: bilateral oophorectomy (O) (n=40) and sham surgery (S) (n=40). At 90 days of age, groups O and S were randomly subdivided into four groups, according to whether 0.1 mg/kg of ZA or distilled water (DW) was intraperitoneally administered: OZA (n=20), ODW (n=20), SZA (n=20), and SDW (n=20). The animals were sacrificed at 9 and 12 months after the administration of the substances, and then their right femurs were removed and analyzed biomechanically. Axial compres...
OBJETIVO: Investigar as repercussões clínicas, biomecânicas e histomorfométricas do zoledronato no t...
El ácido zoledrónico (AZ) es el bifosfonato de mayor potencia antirresortiva utilizado para el trata...
Osteoporosis is a skeletal disease characterized by a decrease in bone mass and deterioration of bon...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
ABSTRACTTo investigate clinical, biomechanic and histomorphometric effects of zoledronic acid on ost...
An annual infusion of zoledronic acid (ZOL) reduces fracture risk in osteoporotic patients. Previous...
reduces fracture risk in osteoporotic patients. Previously, we showed that a single ZOL injection in...
WOS: 000376377700003PubMed: 26874629Objectives: This study aims to investigate the effects of zoledr...
SummaryThis study monitored in vivo the effect on bone microarchitecture of initiating antiresorptiv...
The aim of this study was to evaluate the effect of zoledronic acid (ZA) in the ovariectomized rat o...
Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2007.Includes...
Objectives: A model that uses right hind-limb unloading of rats is used to study the consequences of...
Current bisphosphonate therapies effectively prevent bone loss in postmenopausal women. We studied t...
<p>(A) Femur Bone Mineral Density (BMD). (B) Trabecular bone volume on tissue volume (BV/TV) of the ...
Objective: This study aims to evaluate bone repair and the development of the medication related ost...
OBJETIVO: Investigar as repercussões clínicas, biomecânicas e histomorfométricas do zoledronato no t...
El ácido zoledrónico (AZ) es el bifosfonato de mayor potencia antirresortiva utilizado para el trata...
Osteoporosis is a skeletal disease characterized by a decrease in bone mass and deterioration of bon...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
ABSTRACTTo investigate clinical, biomechanic and histomorphometric effects of zoledronic acid on ost...
An annual infusion of zoledronic acid (ZOL) reduces fracture risk in osteoporotic patients. Previous...
reduces fracture risk in osteoporotic patients. Previously, we showed that a single ZOL injection in...
WOS: 000376377700003PubMed: 26874629Objectives: This study aims to investigate the effects of zoledr...
SummaryThis study monitored in vivo the effect on bone microarchitecture of initiating antiresorptiv...
The aim of this study was to evaluate the effect of zoledronic acid (ZA) in the ovariectomized rat o...
Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2007.Includes...
Objectives: A model that uses right hind-limb unloading of rats is used to study the consequences of...
Current bisphosphonate therapies effectively prevent bone loss in postmenopausal women. We studied t...
<p>(A) Femur Bone Mineral Density (BMD). (B) Trabecular bone volume on tissue volume (BV/TV) of the ...
Objective: This study aims to evaluate bone repair and the development of the medication related ost...
OBJETIVO: Investigar as repercussões clínicas, biomecânicas e histomorfométricas do zoledronato no t...
El ácido zoledrónico (AZ) es el bifosfonato de mayor potencia antirresortiva utilizado para el trata...
Osteoporosis is a skeletal disease characterized by a decrease in bone mass and deterioration of bon...